Privia Health Group, Inc.
PRVA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $580,419 | $521,153 | $480,097 | $460,900 |
| % Growth | 11.4% | 8.6% | 4.2% | – |
| Cost of Goods Sold | $519,415 | $473,493 | $434,335 | $412,933 |
| Gross Profit | $61,004 | $47,660 | $45,762 | $47,967 |
| % Margin | 10.5% | 9.1% | 9.5% | 10.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $39,641 | $37,519 | $31,721 | $34,425 |
| SG&A Expenses | $46,601 | $44,324 | $38,643 | $40,887 |
| Sales & Mktg Exp. | $6,960 | $6,805 | $6,922 | $6,462 |
| Other Operating Expenses | $0 | $0 | $1,901 | $1,832 |
| Operating Expenses | $46,601 | $44,324 | $40,544 | $42,719 |
| Operating Income | $14,403 | $3,336 | $5,218 | $5,248 |
| % Margin | 2.5% | 0.6% | 1.1% | 1.1% |
| Other Income/Exp. Net | $2,271 | $2,408 | $2,931 | $2,774 |
| Pre-Tax Income | $16,674 | $5,744 | $8,149 | $8,022 |
| Tax Expense | $6,867 | $2,456 | $2,103 | $2,655 |
| Net Income | $6,861 | $2,687 | $4,220 | $4,399 |
| % Margin | 1.2% | 0.5% | 0.9% | 1% |
| EPS | 0.06 | 0.022 | 0.03 | 0.037 |
| % Growth | 172.7% | -26.7% | -18% | – |
| EPS Diluted | 0.05 | 0.021 | 0.03 | 0.035 |
| Weighted Avg Shares Out | 122,769 | 122,132 | 120,624 | 120,136 |
| Weighted Avg Shares Out Dil | 128,777 | 128,447 | 127,753 | 126,422 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,271 | $2,408 | $2,931 | $2,774 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,766 | $2,583 | $1,901 | $1,832 |
| EBITDA | $19,440 | $8,327 | $7,119 | $7,080 |
| % Margin | 3.3% | 1.6% | 1.5% | 1.5% |